Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587093 · ClinicalTrials.gov registry record · NA
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 669
- Enrollment target
NCT00587093: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00587093 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 669 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587093, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 669 participants
- Enrollment target
Study Summary
The purpose of the research is to determine if blood tests and a CT scan done before surgery can predict how successful the surgery will be. In patients who have cancer of the ovary that has spread, it is hoped that the CT scan will be able to identify the various places where the cancer has spread so that additional surgeons can be available to help with the surgical procedure. If you have confirmed stage 3 or 4 ovarian, fallopian tube, or primary peritoneal cancer, you may undergo a CT scan of the abdomen and pelvis after the surgery to compare how much cancer the surgeon thought was left after surgery to what is seen on CT scan. A CT scan of the chest will be done if your physician thinks it is necessary.
Interventions
- OTHER CA 125 and CT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 669 participants |
| Start Date | 2001-07 |
| Est. Completion | 2018-02-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587093
The ClinicalTrials.gov registry entry for NCT00587093 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 669 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CA 125 and CT scan is the first listed.
NCT00587093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587093 about?
NCT00587093 is a clinical study titled "A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer". The purpose of the research is to determine if blood tests and a CT scan done before surgery can predict how successful the surgery will be. In patients who have cancer of the ovary that has spread, it is hoped that the CT scan will be able to identify the various places where the cancer has spread ...
What is the current status of trial NCT00587093?
This trial is currently completed. It is a NA study. The enrollment target is 669 participants. The study started on 2001-07. Estimated completion is 2018-02-16.
What interventions are being tested in trial NCT00587093?
The interventions under investigation include: CA 125 and CT scan (OTHER).
Who is sponsoring clinical trial NCT00587093?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.